The Other Road to Singularity

In his landmark 1993 paper "The Coming Technological Singularity: How to Survive the Post-Human Era," Vernor Vinge raised four possible paths to the "intelligence explosion" that is the Singularity. The first three involved computers--1. the advent of a computer with what we would call strong "artificial intelligence"; 2. a computer network's more spontaneously developing such intelligence; 3. an integration of human and computer intelligence through advanced mind-machine interfaces (allowing, for example, a human brain with its superior pattern recognition and other abilities to access the vastly superior computational capacities and data storage of computer systems); and 4. a purely biological enhancement of human intelligence.

It is, of course, the case that we hear most about number one, somewhat less about two and three, and least of all about number four, the non-computer, biological option.

Why is that the case?

My impression is that this reflects the observable rate of progress in those areas. Where the computing sector has had "Moore's Law," and the geometrical expansion of the computing power available at any given price (and total computing power on Earth) that goes with it, the medical sector's feats have been . . . less impressive. Indeed, the contrast has been sufficiently pointed, and noted, that the term "Eroom's Law" has been coined to refer to how the development of treatments and cures has, rather than becoming quicker and cheaper in the manner of computers, become slower and more expensive instead.

Amid all that it has been far easier to picture rising computer power beating biotechnology to the finish line in the race to produce a greater-than-human intelligence for decades. In fact, even with some questioning the likelihood of Moore's Law's continuing as microchip fabrication reaches the apparent limits of the possible in silicon, and the long-awaited substitutes prove to be (like so much else these days) "behind schedule," it can still seem that way.